Carcinoma, Hepatocellular
"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Descriptor ID |
D006528
|
| MeSH Number(s) |
C04.557.470.200.025.255 C04.588.274.623.160 C06.301.623.160 C06.552.697.160
|
| Concept/Terms |
Carcinoma, Hepatocellular- Carcinoma, Hepatocellular
- Carcinomas, Hepatocellular
- Hepatocellular Carcinomas
- Liver Cell Carcinoma, Adult
- Liver Cancer, Adult
- Adult Liver Cancer
- Adult Liver Cancers
- Cancer, Adult Liver
- Cancers, Adult Liver
- Liver Cancers, Adult
- Liver Cell Carcinoma
- Carcinoma, Liver Cell
- Carcinomas, Liver Cell
- Cell Carcinoma, Liver
- Cell Carcinomas, Liver
- Liver Cell Carcinomas
- Hepatocellular Carcinoma
- Hepatoma
- Hepatomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".
This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in this website by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 4 | 5 |
| 1996 | 2 | 1 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 3 | 4 |
| 2001 | 6 | 1 | 7 |
| 2002 | 7 | 4 | 11 |
| 2003 | 4 | 3 | 7 |
| 2004 | 6 | 3 | 9 |
| 2005 | 7 | 1 | 8 |
| 2006 | 3 | 1 | 4 |
| 2007 | 8 | 1 | 9 |
| 2008 | 8 | 5 | 13 |
| 2009 | 13 | 4 | 17 |
| 2010 | 16 | 3 | 19 |
| 2011 | 12 | 2 | 14 |
| 2012 | 10 | 1 | 11 |
| 2013 | 17 | 0 | 17 |
| 2014 | 12 | 2 | 14 |
| 2015 | 19 | 2 | 21 |
| 2016 | 14 | 3 | 17 |
| 2017 | 21 | 2 | 23 |
| 2018 | 22 | 1 | 23 |
| 2019 | 36 | 1 | 37 |
| 2020 | 44 | 0 | 44 |
| 2021 | 36 | 2 | 38 |
| 2022 | 48 | 0 | 48 |
| 2023 | 34 | 1 | 35 |
| 2024 | 27 | 5 | 32 |
| 2025 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.
-
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2025 Feb 01; 11(2):136-144.
-
Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial. J Natl Cancer Inst. 2025 Feb 01; 117(2):262-269.
-
Risk of carcinomas among children and adolescents with birth defects. Cancer Epidemiol. 2025 Apr; 95:102748.
-
"Update on pediatric primary liver tumors". Virchows Arch. 2025 Jan; 486(1):23-47.
-
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis. Cancer Res. 2025 Jan 15; 85(2):299-313.
-
Access to Evaluation for Liver Transplantation in the Veterans Health Administration. Dig Dis Sci. 2025 Feb; 70(2):552-565.
-
Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3-Expressing Hepatocellular Carcinoma. Mol Cancer Ther. 2024 Dec 03; 23(12):1815-1826.
-
Outcomes of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation Utilizing Extended Criteria Donor Grafts. Transplant Proc. 2024 Dec; 56(10):2203-2212.
-
Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial. Gut. 2024 Nov 11; 73(12):2037-2044.
-
SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma. JCI Insight. 2024 Nov 08; 9(21).